KCNJ11 Gene Hyperinsulinemic Hypoglycemia Type 2 Genetic Test
Test Name: KCNJ11 Gene Hyperinsulinemic Hypoglycemia Type 2 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 3200.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for KCNJ11 Gene Hyperinsulinemic Hypoglycemia Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinemic Hypoglycemia Type 2.
Test Details
The KCNJ11 gene is a gene that provides instructions for making a protein called the inward rectifier potassium channel 6 (Kir6.2). This protein is found in the beta cells of the pancreas and plays a crucial role in regulating insulin secretion.
Hyperinsulinemic hypoglycemia type 2 (HH2) is a rare genetic disorder characterized by abnormally high levels of insulin in the blood, leading to low blood sugar levels (hypoglycemia). This condition is typically diagnosed in infancy or early childhood and can cause symptoms such as seizures, developmental delays, and difficulty feeding.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of KCNJ11 gene hyperinsulinemic hypoglycemia type 2, NGS genetic testing can be used to identify specific mutations or variations in the KCNJ11 gene that are associated with the condition.
By identifying these genetic changes, NGS genetic testing can help confirm a diagnosis of hyperinsulinemic hypoglycemia type 2 and provide valuable information for treatment and management of the condition. It can also be used for carrier testing in families with a history of the disorder or for prenatal testing in cases where there is a known familial mutation.
Overall, KCNJ11 gene hyperinsulinemic hypoglycemia type 2 NGS genetic testing is a valuable tool in the diagnosis and management of this rare genetic disorder.
| Test Name | KCNJ11 Gene Hyperinsulinemic hypoglycemia type 2 Genetic Test |
|---|---|
| Components | |
| Price | 3200.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for KCNJ11 Gene Hyperinsulinemic hypoglycemia type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinemic hypoglycemia type 2 |
| Test Details |
The KCNJ11 gene is a gene that provides instructions for making a protein called the inward rectifier potassium channel 6 (Kir6.2). This protein is found in the beta cells of the pancreas and plays a crucial role in regulating insulin secretion. Hyperinsulinemic hypoglycemia type 2 (HH2) is a rare genetic disorder characterized by abnormally high levels of insulin in the blood, leading to low blood sugar levels (hypoglycemia). This condition is typically diagnosed in infancy or early childhood and can cause symptoms such as seizures, developmental delays, and difficulty feeding. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of KCNJ11 gene hyperinsulinemic hypoglycemia type 2, NGS genetic testing can be used to identify specific mutations or variations in the KCNJ11 gene that are associated with the condition. By identifying these genetic changes, NGS genetic testing can help confirm a diagnosis of hyperinsulinemic hypoglycemia type 2 and provide valuable information for treatment and management of the condition. It can also be used for carrier testing in families with a history of the disorder or for prenatal testing in cases where there is a known familial mutation. Overall, KCNJ11 gene hyperinsulinemic hypoglycemia type 2 NGS genetic testing is a valuable tool in the diagnosis and management of this rare genetic disorder. |
